Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

FARAFARA Cure FA

PTC Therapeutics to acquire Agilis Biotherapeutics

FARA is pleased to share news that one of our gene therapy partners, Agilis Biotherapeutics, has been acquired by PTC Therapeutics. PTC Therapeutics will bring expertise in rare disease drug development and additional resources to advance the work that Agilis has initiated in FA gene therapy. We are looking forward working with PTC Therapeutics to accelerate this important FA program.

Read the entire article HERE


About the Author

Jen Farmer

Jen Farmer

Executive Director

SHARE

FacebookTwitterLinkedInYoutube
Event A.jpg

 

Archived in
  Scientific News


 

 

Tagged in
FARA Scientific News